Easy Bio Overview

  • Year Founded
  • 1988

Year Founded

  • Status
  • Public

  • Employees
  • 143


  • Stock Symbol
  • 353810

Stock Symbol

  • Investments
  • 8

  • Share Price
  • $2.46
  • (As of Tuesday Closing)

Easy Bio General Information


Easy Bio Inc is a bio-technology company. The company conducts research, manufactures and markets animal feed products in South Korea.

Contact Information

Formerly Known As
EASY System
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Food Products
Other Industries
Environmental Services (B2B)
Stock Exchange
Primary Office
  • 4th floor, 310
  • Gangnam-daero, Gangnam-Gu
  • Seoul, 06253
  • South Korea
+82 00-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Easy Bio Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.46 $2.45 $2.22 - $3.87 $83.9M 34.1M 95.7K $0.29

Easy Bio Financials Summary

In Thousands,
TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 122,162 162,053 162,567 983,804
Revenue 124,656 120,389 113,022 74,637
EBITDA 16,705 13,105 15,376 13,240
Net Income 9,874 7,066 9,492 8,830
Total Assets 131,174 124,958 98,901 82,336
Total Debt 70,783 65,114 43,040 34,135
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Easy Bio Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Easy Bio‘s full profile, request access.

Request a free trial

Easy Bio Patents

Easy Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230309580-A1 Feed additive composition containing erythritol Pending 07-Sep-2020 0000000000
AU-2002365361-A1 Lactoferricin gene and transformant expressing lactoferricin Inactive 30-Nov-2001 000000000
US-20060148029-A1 Point mutations; plasmids; fusion proteins Active 30-Nov-2001 000000000
US-7186795-B2 Point mutations; plasmids; fusion proteins Inactive 30-Nov-2001 C07K14/79

Easy Bio Executive Team (4)

Name Title Board Seat Contact Info
Stevenson Hwang Chief Executive Officer
Young Hyun Vice Chairman
You’re viewing 2 of 4 executive team members. Get the full list »

Easy Bio Board Members (2)

Name Representing Role Since
Young Hyun Self Vice Chairman 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Easy Bio Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Easy Bio Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Furst-McNess 02-Aug-2021 0000000000 Other Agriculture 000000000
DFS Oskaloosa 24-Dec-2018 0000000000 Animal Husbandry
Jungdawn 27-Nov-2015 000000000 Food Products
Seoul Feed Company 01-Jan-2015 000000000 Other Consumer Non-Durables
Samyang Holdings (Animal food manufacturing business) 30-Jan-2012 Merger/Acquisition 000.00 Food Products
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Easy Bio Subsidiaries (4)

Company Name Industry Location Founded
E&Venture Partners Corporate Venture Capital Seoul, South Korea 2018
Seoul Feed Company Other Consumer Non-Durables Incheon, South Korea 0000
DFS Oskaloosa Animal Husbandry Oskaloosa, IA 0000
Furst-McNess Other Agriculture Freeport, IL 0000
To view Easy Bio’s complete subsidiaries history, request access »

Easy Bio Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
Jungdawn 27-Nov-2015 000000000 00000000 Completed
  • 0000 000
Maniker F&G 01-Jun-2011 Merger/Acquisition Completed
To view Easy Bio’s complete exits history, request access »